Hematology
New genetic engineering techniques are likely to cure hemophilia patients
Published in Blood Weekly, September 11th, 2003
"In the last three decades, hemophilia has moved from the status of a neglected and often fatal hereditary disorder to that of a fully defined group of molecular-pathological entities for which safe and effective treatment is available. Hemophilia is likely to be the first widespread severe genetic condition to be cured by gene therapy in the third millennium," according to recent research from Italy.
"In the socio-economic arena it remains a challenge to humanity to know that four-fifths of the world's hemophiliacs still receive no treatment at all," noted P.M. Mannucci,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-09-11)
More Articles from Blood Weekly
- Blood Substitute
Novel oxygen carrier may improve stroke treatment - Fanconi Anemia
Minimal conditioning safe, effective for FA patients undergoing stem cell transplantation - Cancer Therapy
Gleditsia sinensis fruit extract has antiangiogenic potential - Hematology
Abnormal hemoglobin carriers identified by low glycohemoglobin levels, genetic screening - Pulmonary Complications
Lymphomatoid granulomatosis is a risk following renal transplant - Stem Cell Transplantation
Factors involved in post-transplant IIP identified - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
